Medical Research and Clinical Trial Management Training Course

Clinical trials turn a research hypothesis into evidence that regulators, clinicians, and patients can trust, and getting there depends on disciplined operations more than on good intentions. This course examines how a trial moves from a written protocol through ethics approval, site activation, participant enrollment, monitoring, and final data lock, and it treats each stage as a set of concrete decisions with documented consequences. The emphasis is operational: what a coordinator, monitor, or sponsor representative actually does to keep a study compliant with ICH-GCP (E6) and the applicable regulatory framework.

Across the units you will work through the documentation and controls that hold a study together, including the protocol and its amendments, the informed consent process, the case report form, the monitoring plan, and the audit trail inside an electronic data capture system. The material follows a trial through phases I to IV and connects sponsor obligations, site responsibilities, and the oversight exercised by an institutional review board or ethics committee, so participants leave able to see where compliance is earned or lost.

Why this matters

A single unresolved protocol deviation, an inadequate consent record, or a data discrepancy that surfaces during an FDA or EMA inspection can delay a submission, trigger a warning letter, or invalidate a site's data entirely. Clinical research now spans multi-country studies, contract research organizations, and decentralized and digital designs, alongside increasingly detailed expectations under ICH-GCP E6(R3), which places the burden on sponsors and sites to show a quality management system that is documented and followed, not assumed. Teams that understand the reasoning behind good clinical practice protect participants and produce data that survives scrutiny.

Because the operational side of trials sits close to questions of participant rights, liability, and duty of care, it helps to pair this grounding with a clear view of the surrounding legal and ethical duties covered in Medical Ethics and Legal Compliance. Sponsors, sites, and monitors who share a common vocabulary around consent, confidentiality, and reporting obligations resolve issues faster and reduce the risk of findings during audits and inspections.

What you will be able to do afterwards

By the close of the sessions, you will be prepared to design, run, and oversee clinical research to a compliant, ethical standard:

Interpret trial protocols, schedules of assessments, and endpoints.
Apply ICH-GCP E6, informed consent, and the trial master file.
Structure ethics committee submissions and manage amendments.
Plan site initiation, monitoring visits, and CAPA responses.
Evaluate EDC and case report form data ahead of database lock.
Map FDA, EMA, and ICH obligations to inspection readiness.

Course outline

Unit 1: Introduction to Medical Research and Clinical Trials

Trials from first-in-human to post-marketing phase IV.
Phase I to III, observational, and interventional designs.
Sponsors, investigators, and contract research bodies.
The Declaration of Helsinki and Belmont Report principles.

Unit 2: Protocol Development and Ethical Approvals

Trial endpoints, eligibility, and schedule of assessments.
Vulnerable populations and re-consent after amendments.
Institutional review boards and serious adverse events.
Conflicts of interest, disclosure, and oversight.

Unit 3: Trial Operations and Site Management

Feasibility assessment and delegation-of-authority logs.
Recruitment and retention within eligibility limits.
Source data verification and risk-based monitoring.
Multidisciplinary research teams and clear communication.

Unit 4: Data Collection, Analysis, and Quality Assurance

EDC platforms, edit checks, and the audit trail.
Query management and source data verification.
Statistical analysis plan, endpoints, and missing data.
Corrective and preventive action, and inspection readiness.

Unit 5: Regulatory Compliance and Future Trends

International requirements set by the FDA, EMA, and ICH.
Good Clinical Practice and ICH-GCP E6 responsibilities.
Decentralized trials, remote monitoring, and wearables.
Adaptive designs and real-world evidence.

How the course is delivered

Learning is built on expert-led discussion, worked protocol examples, and guided reviews of documented trial documentation — consent forms, monitoring reports, and inspection findings. Participants examine published trials and audit cases to see how design, oversight, and data decisions affected integrity and participant safety.

Who should attend

The material is written for anyone who plans, coordinates, or oversees trials:

Clinical research coordinators and study nurses managing site activities and participant visits.
Clinical research associates and monitors responsible for site oversight and source verification.
Sponsor and contract research organization staff in project management, regulatory affairs, or quality assurance.
Data managers and biostatisticians who work with EDC systems and trial datasets.
Investigators, pharmacists, and ethics committee members seeking a fuller view of trial operations.

About EuroQuest International Training

Active since 2015, EuroQuest International Training keeps its head office in Bratislava, Slovakia, and now holds over 1,000 courses in its catalog and a community of 15,000+ professionals trained. Sessions are hosted in Barcelona, Paris, Istanbul, Geneva, Dubai, London, and Vienna, letting research teams reach an expert-led classroom without long travel.

Frequently asked questions

Do I need prior trial experience to follow the course?

No. It starts from the phases and stakeholders of clinical research and builds toward oversight, so newer coordinators and investigators can keep pace while experienced staff sharpen their practice. Curiosity about method and compliance matters more than a set number of trials.

Which guidelines does the course work from?

It treats ICH-GCP (E6), the Declaration of Helsinki, and regulatory expectations from the FDA, EMA, and national authorities as subject matter, and walks through protocol design, informed consent, IRB and ethics-committee review, and EDC-based data management.

Will finishing qualify me to run a trial on my own?

It supports that ambition without conferring it. The training is educational and offers no clinical, medical, or regulatory authorization for a study; what you keep is a EuroQuest certificate of completion listing the subjects you addressed.

Related courses

Register for this course

Claim a seat and sharpen how your team designs and governs research. Write to our team for available dates, city options, and enrollment for individuals or research units.